More on LEGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $21.75 |
|
|||
| Open | $21.52 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $21.90 | ||||
| Day Low | $21.41 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 812,214 | ||||
- H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
- Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
- Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
- Parabilis Medicines adds former J&J oncology executive to board
- Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
- Form 4 Legend Biotech Corp For: Aug 14 Filed by: BASH ALAN
- Form 6-K Legend Biotech Corp For: Aug 18
- Legend Biotech Corp. (LEGN) PT Lowered to $24 at TD Cowen
- Legend Biotech Corp. (LEGN) PT Raised to $49 at Morgan Stanley
- ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
Entities mentioned with LEGN
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
